DUBLIN--(BUSINESS WIRE)--The "Infectious Disease Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global infectious disease testing market to grow with a CAGR of around 7.5% over the forecast period from 2022-2028.
The report on the global infectious disease testing market provides qualitative and quantitative analysis for the period from 2022 to 2028. The study on infectious disease testing market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.
The report on infectious disease testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global infectious disease testing market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global infectious disease testing market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
What does this Report Deliver?
- Comprehensive analysis of the global as well as regional markets of the infectious disease testing market.
- Complete coverage of all the segments in the infectious disease testing market to analyze the trends, developments in the global market and forecast of market size up to 2028.
- Comprehensive analysis of the companies operating in the global infectious disease testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co
- Bio-rad Laboratories
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers AG
- Roche Diagnostics
- Gen-probe, Inc.
- Johnson and Johnson
- Biomerieux SA
- Alere, Inc.
Report Findings
1) Drivers
- High prevalence of infectious diseases
- Increasing awareness among the population about communicable diseases
2) Restraints
- High cost of diagnostic instrument and tests
3) Opportunities
- Shifting healthcare trend towards more precise, safer and effective diagnosis and advances in molecular biology
Segment Covered
The Global Infectious Disease Testing Market by Technology
- Molecular Testing
- Microbiology
- Immunodiagnostics
The Global Infectious Disease Testing Market by Product
- Equipment
- Reagents
- Software
The Global Infectious Disease Testing Market by Application
- Hepatitis
- HIV
- Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
- Human Papillomavirus (HPV)
- Respiratory Tract Infections
- Others
The Global Infectious Disease Testing Market by End User
- Hospitals Laboratories
- Reference Labs
- Physician Office Labs
- Academics Lab
- Others
For more information about this report visit https://www.researchandmarkets.com/r/2rugvl
